signalgroup

Get more out of your business.

Reach it with Microsoft Dynamics 365 Business Central.

May 27, 2020 signalgroup

Robust Biosimilars Market Could Save U.S. Taxpayers $7 Billion Annually, New Analysis Finds

May 21, 2020 signalgroup

AMA: U.S. Health Insurance Plans Prefer Brand Biologics Twice as Often as Lower-Cost Biosimilars

April 30, 2020 signalgroup

ICYMI: After Congress Approved $3 Trillion in Spending Amid the COVID-19 Pandemic, Biosimilars Can Reduce Health Care Costs for Employers and the U.S. Health Care System

April 27, 2020 signalgroup

ICYMI: Expert Encourage Increasing Biosimilar Use to Lower Health Care Costs; Study Finds Biosimilars Could Lower Employers Insurance Costs

March 31, 2020 signalgroup

Self-Insured Employers Could Have Saved Up to $1.4 Billion in 2018 with Lower-Cost Biosimilars

March 13, 2020 signalgroup

ICYMI: This Week, HHS Secretary Azar, Congressman Burgess, Physicians and Patients Pointed to Biosimilars to Save Seniors and Taxpayers Money; Congress Introduces Two Bills to Lower Costs with Biosimilars

March 13, 2020 signalgroup

The Biosimilars Forum Applauds Senators McSally (R-AZ) and Jones (D-AL) Introduction of S. 3466, the ACCESS for Biosimilars Act of 2020

March 11, 2020 signalgroup

The Biosimilars Forum Supports Congressmen Cardenas, Hudson, Fitzpatrick, & Craig Introduction of H.R. 6179 — Lowering Costs For Taxpayers and Medicare Seniors with Biosimilars

March 5, 2020 signalgroup

The Importance of Dispelling Misinformation About Biosimilar Therapies

February 10, 2020 signalgroup

White House Budget Proposal Recognizes Urgent Need to Increase Patient Access to Lower-Cost Biosimilars